查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513944

研究 ELISA（酵素结合免疫吸附检测法）全球市场

Research ELISA (Enzyme-Linked Immunosorbent Assay)
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 266 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球 ELISA（酵素结合免疫吸附检测法）研究市场预计将达到 6.923 亿美元

ELISA（酵素结合免疫吸附检测法）的全球研究市场预计到 2023 年将达到 5.382 亿美元，在 2023-2030 年分析期间将以 3.7% 的复合年增长率增长，到 2030 年预计将达到 6.923 亿美元。 ELISA套件是本报告分析的细分市场之一，预计复合年增长率为 3.5%，到分析期结束时将达到 4.786 亿美元。在分析期间，ELISA 开发套件和抗体对部分预计将以 4.1% 的复合年增长率成长。

美国市场预估为1.456亿美元，中国预期复合年增长率为6.1%

到 2023 年，美国研究 ELISA（酵素结合免疫吸附检测法）市场预计将达到 1.456 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.402亿美元，2023-2030年分析期间复合年增长率为6.1%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 2.0% 和 3.0%。在欧洲，德国的复合年增长率预计为 2.4%。

全球调查 ELISA（酵素结合免疫吸附检测法）市场 - 主要趋势和驱动因素总结

酵素结合免疫吸附检测法(ELISA) 是一种广泛使用的分析生化测定，旨在检测和定量胜胜肽、蛋白质、抗体和荷尔蒙等物质。此测定利用抗体的特异性来检测复杂样本中特定生物分子的存在。 ELISA 基于抗原抗体相互作用的原理，其中酶联抗原或抗体在目标分子存在的情况下产生可测量的信号（通常是颜色变化）。此技术广泛应用于临床诊断、食品安全、环境监测等各领域的诊断、品管和研究。

ELISA 的稳健性和多功能性源于其提供高度特异性和敏感结果的能力，这使其在临床和研究环境中都至关重要。在临床诊断中，ELISA 对于检测病毒和细菌感染、自体免疫疾病和过敏等疾病至关重要。例如，它通常用于检测 HIV、肝炎和 SARS-CoV-2。在食品业，ELISA 透过检测过敏原、毒素和污染物来帮助确保食品安全。此外，环境机构也采用 ELISA 来监测水和土壤中的污染物和病原体。随着各种形式（包括直接、间接、夹心和竞争性 ELISA）的开发，检测方法变得更加适应性强，每种形式都根据特定的分析需求量身定制。

ELISA 市场的成长是由技术进步、慢性病和感染疾病的流行以及对具有成本效益和可靠的诊断方法的需求不断增长等多种因素推动的。自动化高通量 ELISA 系统的开发等技术创新大大提高了检测效率和准确性。癌症和糖尿病等慢性病以及新出现的感染疾病的迅速增加，增加了对精确诊断工具的需求，从而推动了对 ELISA 的需求。此外，个人化医疗的不断增长趋势以及 ELISA 在药物开发和治疗反应监测中的广泛应用正在进一步推动市场成长。人们对食品和环境安全的认识不断提高以及监管关注度的提高也促进了 ELISA 市场的扩大。

受访企业范例（共27家）

  • American Laboratory Products Company（ALPCO）（US）
  • BD Biosciences（US）
  • BioLegend, Inc.（US）
  • Bio-Rad Laboratories, Inc.（US）
  • Enzo Life Sciences, Inc.（US）
  • Merck KGaA
  • Mercodia AB（Sweden）
  • R&D Systems, Inc.（US）
  • Thermo Fischer Scientific Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6082

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach US$692.3 Million by 2030

The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$538.2 Million in the year 2023, is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$478.6 Million by the end of the analysis period. Growth in the ELISA Development Sets & Antibody Pairs segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$145.6 Million While China is Forecast to Grow at 6.1% CAGR

The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$145.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$140.2 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market - Key Trends and Drivers Summarized

Enzyme-Linked Immunosorbent Assay (ELISA) is a widely utilized analytical biochemistry assay, designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. This assay leverages the specificity of antibodies to detect the presence of specific biomolecules in complex samples. ELISA operates on the principle of antigen-antibody interactions, where an enzyme-linked antigen or antibody produces a measurable signal, typically a color change, in the presence of its target molecule. This technique has found extensive applications in diagnostics, quality control, and research across various fields including clinical diagnostics, food safety, and environmental monitoring.

ELISA's robustness and versatility stem from its ability to deliver highly specific and sensitive results, making it indispensable in both clinical and research settings. In clinical diagnostics, ELISA is crucial for disease detection, including viral and bacterial infections, autoimmune diseases, and allergies. For instance, it is commonly used in the detection of HIV, hepatitis, and SARS-CoV-2. In the food industry, ELISA helps ensure food safety by detecting allergens, toxins, and contaminants. Moreover, environmental agencies employ ELISA to monitor pollutants and pathogens in water and soil. The assay's adaptability is further enhanced by the development of various formats, such as direct, indirect, sandwich, and competitive ELISA, each tailored for specific analytical needs.

The growth in the ELISA market is driven by several factors including advancements in technology, increasing prevalence of chronic and infectious diseases, and the rising demand for cost-effective and reliable diagnostic methods. Technological innovations, such as the development of automated and high-throughput ELISA systems, have significantly improved the efficiency and accuracy of the assays. The surge in chronic diseases like cancer and diabetes, alongside emerging infectious diseases, has amplified the need for precise diagnostic tools, thus boosting the demand for ELISA. Additionally, the growing trend towards personalized medicine and the expanding application of ELISA in drug development and monitoring therapeutic responses have further fueled market growth. The increasing awareness and regulatory emphasis on food and environmental safety also contribute to the expanding ELISA market, as these assays are vital for ensuring compliance with safety standards.

Select Competitors (Total 27 Featured) -

  • American Laboratory Products Company (ALPCO) (US)
  • BD Biosciences (US)
  • BioLegend, Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Enzo Life Sciences, Inc. (US)
  • Merck KGaA
  • Mercodia AB (Sweden)
  • R&D Systems, Inc. (US)
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Use of ELISA in Drug Discovery and Development Drives Adoption
    • Advancements in ELISA Technology Propel Growth in Research Applications
    • Growing Prevalence of Chronic and Infectious Diseases Spurs Demand for ELISA
    • Here's How Automation in ELISA Testing Drives Market Expansion
    • Adoption of ELISA in Environmental Monitoring Throws the Spotlight on Market Growth
    • Increasing Demand for Rapid and Point-of-Care Testing Spurs ELISA Market Growth
    • Growing Use of ELISA in Vaccine Development Expands Market Opportunities
    • Adoption of Multiplex ELISA Platforms Generates Demand in Research Settings
    • Increasing Number of Clinical Trials Using ELISA Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for ELISA Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for ELISA Development Sets & Antibody Pairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • INDIA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030
  • AFRICA
    • Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION